Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia
Clinical trial NCT05828108 · COMPLETED
Trial details
- NCT number
- NCT05828108
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-25
- Primary completion
- 2025-08-28
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.